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Abstract
Background The recommendation for using posterior-
stabilized (PS) implants in patellectomy patients undergo-
ing total knee arthroplasty (TKA) is based on older case
series with heterogeneous patient populations. The use of
cruciate-retaining implants in these patients has not been
evaluated with more contemporary implant designs.
Questions/purposes The purpose of this study was to
evaluate the survivorship and functional outcomes (Knee
Society score, presence of an extensor lag, and range of
motion) of cruciate-retaining (CR) TKA in patients with
prior patellectomy.
Methods Between 1986 and 2012, we performed 27 CR
TKAs in 25 patients after patellectomy. Of those, 23 CR
TKAs in 21 patients were available for followup at a
minimum of 2 years (mean, 11.2 years; range, 2.3–
25.1 years). In this retrospective study, we queried a pro-
spectively maintained database to assess functional
outcomes and survivorship.
Results Aseptic loosening-free survival was 100% at 5
and 10 years, and survival with revision for any reason as
the outcome was 96% at 5 years (95% confidence interval
[CI], 87.7%–100%) and 84% at 10 years (95% CI, 69.5%–
100%). One patient was revised for aseptic loosening at
10.2 years postoperatively. Mean Knee Society scores
improved from 36 ± 13 preoperatively to 92 ± 9.6 at
followup. Extensor lag was present in seven patients pre-
operatively and only three at followup. Average knee
flexion at followup was 112 ± 12.5.
Conclusions In this study we found good long-term sur-
vivorship and functional outcomes with a CR implant
design in patients following patellectomy. Earlier studies
have favored PS over CR implants for patients with
patellectomies. We believe this series suggests that CR
TKA is indeed an option in patients with patellectomy.
Level of Evidence Level IV, therapeutic study. See
Guidelines for Authors for a complete description of levels
of evidence.
Introduction
It has been proposed that the AP intrinsic stability of the
knee is a result of a four-bar linkage system consisting of
the patella and quadriceps tendons and the anterior and
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posterior cruciate ligaments [15]. This mechanism affords
AP knee stability during knee flexion but is contingent on a
normal extensor mechanism. The patella serves to position
the quadriceps and patella tendons such that they are par-
allel to the anterior and posterior cruciate ligaments,
respectively. This allows those pairs of ligaments to work
in concert to afford stability to the knee. When the patella
is absent such as in a patellectomized patient, the four-bar
linkage system is disrupted [4, 15].
In a patient with knee osteoarthritis, often the anterior
cruciate ligament is absent or deficient, which, when
combined with a disrupted four-bar linkage system in a
patellectomized patient, can result in a loss of intrinsic AP
stability of the knee. For patients undergoing TKA in this
setting, increased stresses may theoretically be transferred
to the prosthetic components [10]. It has been suggested
that posterior-stabilized (PS) designs are preferred over
cruciate-retaining (CR) prostheses in patellectomy patients
undergoing TKA because of intrinsic AP stability provided
by the PS prosthesis itself [10, 11, 15]. Most of the early
literature in the 1980s and 1990s on TKA in patients with
prior patellectomy has supported the use of PS implants
over CR designs [2, 3, 5, 10, 12, 14]. However, most of
those studies had very small sample sizes, heterogeneous
patient populations with both revisions and primary knee
arthroplasties included, and multiple implant designs,
making it difficult to draw any meaningful conclusions.
Furthermore, most of the implant designs used in those
studies are no longer in clinical practice.
The purposes of this study, therefore, were (1) to eval-
uate the survivorship of CR TKA in patients with prior
patellectomy at a mean of 11 years (range, 2–25 years);
and (2) to evaluate the functional outcomes (Knee Society
score, presence of an extensor lag, and ROM) of those
same patients.
Patients and Methods
A prospectively maintained database of two senior
arthroplasty surgeons (TST, RDS) was searched for all
patients who underwent a primary CR TKA after a
previous ipsilateral patellectomy. Between 1986 and
2012, 27 CR TKAs in 25 patients were identified with a
minimum followup of 2 years (mean, 11 years; range, 2–
25 years). During this time period we did not identify
any patients with a prior patellectomy who underwent a
PS TKA. Three patients were lost to followup before
their 2-year visit, and one patient had surgery less than
2 years before data collection began for the present
study. None of the excluded patients had undergone
revision before being lost. The one patient who under-
went surgery less than 2 years ago had not undergone
revision at the time of this study. The study population,
therefore, consisted of 23 CR TKAs in 21 patients. There
were six deaths; because all six had been followed for at
least 2 years, the data from those patients were included
in the analysis.
The CR implants used were 11 PFC (DePuy Orthopae-
dics Inc, Warsaw, IN, USA) (all done before 1995), seven
Sigma fixed-bearing (DePuy Orthopaedics Inc), and five
Sigma rotating platform (DePuy Orthopaedics Inc).
Demographic data were recorded from the database for
each patient. The patients had a mean age of 57.8 ±
9.4 years. Mean preoperative Knee Society score (KSS) was
36.4 ± 13 and mean preoperative Knee Society functional
score was 51.1 ± 16. The mean time interval between pat-
ellectomy and TKA was 23.4 years (range, 3–52 years).
Reasons for patellectomy included recurrent patella insta-
bility in eight, patella fracture in seven, patella infection in
three, severe patellofemoral osteoarthrosis in one, and
unclear reasons in the remaining four who each reported
childhood patella problems without specific details.
Clinical outcomes were assessed by comparing preop-
erative and postoperative KSS for each patient, which were
graded according to the following scoring system: 85 to
100 excellent, 70 to 84 good, 60 to 69 fair, and \ 60 poor
[7]. The ability of the patient to ascend and descend stairs
was recorded from the KSS functional outcome score
questionnaire [7]. Preoperative and postoperative knee
ROM was assessed using a goniometer or at the operating
surgeon’s discretion. All revision surgeries were recorded
as well as the specific reason for each revision. An attempt
to contact all patients by telephone was performed to
confirm accuracy of all revisions recorded in the database.
Survivorship analysis was conducted using the Kaplan-
Meier survival method through the ‘‘survival’’ package in R
[16, 17]. Survival curves were calculated for patients under-
going revision for aseptic loosening and/or instability alone
with other indications for revision treated as censored data.
Additional survival analysis was performed for all patients
undergoing revision for any reason (uncensored revisions).
Ninety-five percent confidence intervals were estimated
through thesurvival model and given as log-based percentages.
Results
Aseptic loosening-free survival was 100% at 5 and
10 years postoperatively (Fig. 1). Total revision-free sur-
vival for any reason was 96% at 5 years (95% confidence
interval [CI], 87.7%–100%) and 84% at 10 years (95% CI,
69.5%–100%) (Fig. 2). Five patients underwent revision
during followup. Two patients underwent polyethylene
exchange at 6.75 years and 11 years postoperatively for
wear and osteolysis without loosening of the components.
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One patient developed a late infection 7 years postopera-
tively and underwent a two-stage exchange. One patient
had repeat falls during the first postoperative year with
resultant collateral ligament instability requiring revision
with increased component constraint. One patient was
revised for aseptic loosening of the tibial component at
10.2 years postoperatively.
Mean KSS improved from 36.4 ± 13 preoperatively to
92.1 ± 9.6 at 11.2 years average followup. Preoperative KSS
were all classified as poor, and at latest followup (including
after any revision surgery), there were 18 excellent, four good,
and one fair result. Seven patients had a preoperative extensor
lag ranging from 5 to 15. At latest followup, three patients
had a persistent extensor lag: one each measuring 5, 10, and
15. Average knee flexion at followup was 112 ± 12.5
(range, 90–135).
Discussion
The recommendation that patellectomy patients undergo-
ing TKA should have a PS design has been based on
limited evidence from prior studies, which evaluated het-
erogeneous groups [3–5, 7, 12, 14]. It has been theorized
that the loss of intrinsic knee AP stability in a patellectomy
patient would predispose a CR TKA to early failure sec-
ondary to aseptic loosening and/or instability. However,
this has never been shown convincingly in the literature.
Prior comparative studies such as that by Paletta and
Laskin had very small sample sizes with only nine patients
in their PS group [14]. Despite being a comparative study,
it is difficult with such small numbers to draw meaningful
conclusions regarding superiority of one type of TKA over
another in patellectomy patients. In the current study, with
CR implants, patients with a prior patellectomy demon-
strated excellent survivorship and functional outcomes at a
mean of 11 years.
This study is subject to a number of limitations. As a
result of a retrospective design, the current study is subject
to selection bias; however, all patellectomy patients who
underwent TKA were considered for inclusion, and we
were unable to find any patients with prior patellectomy
who underwent a primary PS TKA in the senior authors’
database. The lack of a comparison group is another
weakness, but the relative infrequency of patellectomy
poses a logistical challenge to conducting such a random-
ized or even comparative study. The few comparative data
available on this topic involve smaller groups than the
group we evaluated [14] or evaluations of more heteroge-
neous (or no longer available) implants [12]. Even so, as a
result of a lack of a comparison group, we are unable to
comment on the comparativeness of CR and PS TKA in
this series of patellectomy patients. The authors would
suggest a multiinstitutional comparative study as a future
possibility. Additionally, the patients in this study did not
undergo objective AP knee translation measurement to
more accurately delineate AP stability of the knee, and this
study is subject to assessor bias, which may be relevant to
surgeon-assessed outcomes such as ROM and extensor lag.
Finally, three patients were lost to followup before the 2-
year minimum. If they have undergone revision elsewhere,
that would diminish the survivorship reported here.
In this study, CR TKA in patellectomized patients
demonstrated survivorship of 100% at 10 years with
Fig. 1 Kaplan-Meier survivorship curve with revision for aseptic
loosening as the endpoint with 95% CIs (dotted lines) is
demonstrated.
Fig. 2 Kaplan-Meier survivorship curve with revision for any reason
as the endpoint with 95% CIs (dotted lines) is demonstrated.
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revision for aseptic loosening as the endpoint. There are no
prior studies on survivorship of CR TKA postpatellectomy
with which to compare. The only other series on CR TKA
postpatellectomy recently reported no cases of revision at
midterm followup [6]. When considering revision for any
reason as the outcome, we found 10-year survivorship to be
84%. Comparatively, Yao et al. [18] reported a large series
of TKA after patellectomy, in which 48 of 52 implants
were PS, and found an overall 19.2% revision rate at mean
5.75-year followup. Although survivorship of PS and CR
implants is similar in patellectomy patients, they are both
worse when compared with primary TKA in patients with
intact patellae, which has been shown to have 10-year
survivorship ranging from 93% to 98% [1, 9, 13].
In general, studies have shown inferior functional out-
comes of TKA in patellectomy patients when compared
with those with an intact patella [8, 12, 18]. Some have
reported inferior functional outcomes of CR TKA when
compared with PS TKA in patellectomy patients [14],
whereas others have not shown a difference in functional
outcomes between implant designs [18]. Paletta and Laskin
[14] reported an average KSS score of 67 with cruciate
retention compared with 89 with PS TKA in patellectom-
ized patients at mean 5-year followup. By contrast, Kang
et al. [8] reported a mean KSS score of 82.5 in their CR
group and found no difference compared with PS patients.
In the current study, the average KSS score was 92.1 at
mean 11.2 years followup, which is comparable to prior PS
cohorts. We also found mean knee flexion to be 111 at
followup, which is comparable to the 118 of knee flexion
shown in the recent midterm report on CR TKA after
patellectomy by Dahiya et al. [6]. Similar knee flexion arcs
of 104 and 110 have been shown in PS TKA for patel-
lectomy and intact patellae, respectively [18].
In this case series of TKA in patients with prior patel-
lectomy, we found good survivorship and functional
outcomes with a CR implant design at mean 11.2 years
followup. Although we cannot recommend this approach—
or discount an alternative treatment such as PS TKA—we
believe that these data suggest that CR TKA is a potentially
viable option, and multicenter studies will be needed to
draw firmer conclusions in terms of its efficacy relative to
PS TKA in patients who have had patellectomies.
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